Status:
COMPLETED
Citicoline Dose on Energy Drink Efficacy
Lead Sponsor:
Nathaniel Jenkins
Collaborating Sponsors:
Woodbolt Distribution
Conditions:
Cognitive Performance
Gaming Performance
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The purpose of this study is to determine how the doses of cognitive-enhancing ingredients such as citicoline and caffeine effect the efficacy of acute energy drink consumption for improving cognitive...
Eligibility Criteria
Inclusion
- Fitness: Healthy, recreationally trained (\>2 d/wk physical activity)
- BMI: (\<30kg/m2) or BF \<25% (M) and \<32% (F)
Exclusion
- \<1 hr/wk playing video games
- \>=21 servings of \>=170.5 mL (or \>=6 fl oz) caffeine beverages per week \[(PMID: 33525438)\]
- Injury or illness
- Habitual nicotine or cannabis use
- Use of prescription ADD/ADHD, anti-depressant, or other central acting medication, or previously diagnosed ADD/ADHD, clinical depression, or other mental health condition
- Use of prescription, OTC, or dietary supplements to support sleep, or having been diagnosed with a clinical sleep condition
- Current or prior chronic (\>6 mo) illicit drug or alcohol abuse
- Clinically diagnosed with, or taking medication for a cardiometabolic disease or disorder (e.g., Pre-diabetes, Type II diabetes, high blood pressure, chronic kidney disease, cardiovascular disease, obesity, etc.)
- Clinically diagnosed digestive disorder or sensitivity, or regular use of OTC or dietary supplements to support gastrointestinal pain or discomfort
- Competitive athlete
- Failure to comply with the controls and conditions of this study
Key Trial Info
Start Date :
June 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06890962
Start Date
June 9 2023
End Date
December 1 2023
Last Update
March 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa
Iowa City, Iowa, United States, 52242